IFIH1 and interstitial lung disease: Anti-MDA5 autoantibodies were first described in adults with amyopathic myositis and rapidly progressive ILD: amyopathic myositis is recognised in children but it is rare, and more often patients have mild or progressive muscle disease[20,21].